"SERBP1 (Hero45) is a Novel Link with Ischemic Heart Disease Risk: Associations with Coronary Arteries Occlusion,

Vladislav Shilenok1,2, Ksenia Kobzeva1, Olga Bushueva3,4

  • 1Laboratory of Genomic Research, Research Institute for Genetic and Molecular Epidemiology, Kursk State Medical University, Kursk, Russia.

Insights

Single nucleotide polymorphisms (SNPs) in the SERBP1 gene are associated with a reduced risk of ischemic heart disease (IHD). This finding highlights SERBP1

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Genetics

Background:

  • Ischemic heart disease (IHD) arises from coronary atherosclerosis, a process where chaperone proteins are crucial.
  • SERBP1 (Hero45), an RNA-binding protein with chaperone-like activity, is implicated in atherosclerosis-related diseases.

Purpose of the Study:

  • To investigate the association between SERBP1 single nucleotide polymorphisms (SNPs) and the risk of ischemic heart disease (IHD).
  • To explore the role of SERBP1 in lipid metabolism and coagulation regulation in the context of IHD.

Main Methods:

  • Genotyping of five common SERBP1 SNPs in 2164 subjects (836 IHD patients, 1328 controls) using probe-based PCR.
  • Statistical analysis to determine the association between SERBP1 SNPs and IHD risk, coronary artery stenosis, lipid profiles, and coagulation parameters.

Main Results:

  • Specific SERBP1 SNPs (rs4655707, rs12561767, rs6702742) were significantly associated with a reduced risk of left coronary artery atherosclerosis.
  • SERBP1 loci were linked to lower coronary artery stenosis, improved blood lipid profiles, and favorable blood coagulation parameters.
  • The study identified novel associations between SERBP1, lipid metabolism, and coagulation regulation.

Conclusions:

  • SERBP1 SNPs are associated with a reduced risk of ischemic heart disease.
  • SERBP1 plays a role in modulating IHD risk through its influence on lipid metabolism and coagulation.
  • This research provides the first evidence linking SERBP1 to lipid metabolism and coagulation regulation in the context of IHD.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
108
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71